Related Experiment Video
Updated: Jun 27, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Deciphering Platelet Transcriptomic Profiles in Antiphospholipid Syndrome: Insights into Their Role as Immunological
Yaqing Yang1, Haiyue Jiang1, Zihan Tang1
1Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Platelets in antiphospholipid syndrome (APS) show a proinflammatory signature, acting as immune-thrombotic hubs. This platelet reprogramming offers insights into APS pathogenesis and potential diagnostic strategies.
Area of Science:
- Immunology
- Hematology
- Systems Biology
Background:
- Antiphospholipid syndrome (APS) is an autoimmune disorder causing thrombosis and pregnancy issues, driven by antiphospholipid antibodies (aPLs).
- Platelets play a key role in APS, but their transcriptomic profile in the disease is not well understood.
- Understanding platelet gene expression is crucial for elucidating APS pathophysiology.
Purpose of the Study:
- To characterize the platelet transcriptomic landscape in APS patients.
- To identify key immune-thrombotic pathways involved in APS pathogenesis.
- To explore potential platelet-based diagnostic markers for APS.
Main Methods:
- RNA sequencing was performed on platelets from 43 APS patients, 20 asymptomatic aPL carriers, and 20 healthy controls.
- Bioinformatic analyses were used to identify differentially expressed genes and pathways.
- A 15-gene classifier was developed and validated for discriminating APS from controls.
Main Results:
- Platelets from APS patients displayed significant proinflammatory transcriptional reprogramming, indicating active thrombo-inflammatory roles.
- Activated innate immune pathways (TLRs, NLRs) and neutrophil pathways were identified in APS platelets.
- A 15-gene classifier accurately distinguished APS patients from controls (AUC 0.901-0.948) and revealed differences between APS and asymptomatic aPL carriers.
Conclusions:
- Platelets in APS exhibit a distinct proinflammatory phenotype, functioning as critical immunothrombotic interfaces.
- These findings support the role of platelets in APS pathogenesis and suggest potential for platelet-derived diagnostic and stratification strategies.
- Distinct molecular signatures were associated with anti-β2-glycoprotein I antibodies and different thrombosis types (arterial vs. venous).
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...

